BOT:ASX
Botanix Pharmaceuticals Ltd
A$ ०.००९०
०.००%
(०.००) 1D
नोभेम्बर ११, १६:१०:०९ GMT+११ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$ ०.०१
High
A$ ०.०१
Low
A$ ०.०१
Mkt. cap
२.४९ करोड
Avg. vol.
१.०५ करोड
Volume
१.१२ करोड
52-wk high
A$ ०.१५
52-wk low
A$ ०.०१
EPS
-A$ ०.०३
Shares outstanding
२.७६ अरब
No. of employees
११
Open
A$ ०.०१
High
A$ ०.०१
Low
A$ ०.०१
Mkt. cap
२.४९ करोड
Avg. vol.
१.०५ करोड
Volume
१.१२ करोड
52-wk high
A$ ०.१५
52-wk low
A$ ०.०१
EPS
-A$ ०.०३
Shares outstanding
२.७६ अरब
No. of employees
११
News stories
From web sources and news partners
The Motley Fool
·
३० मिनेट पहिले
History Says 1 Month Has Been the S&P 500's Most Reliable Since 1950. It's Only Weeks Away.
BeInCrypto
·
३५ मिनेट पहिले
S&P 500 Sits 2.5% From a Record High Despite the Stock Market Crash
Bloomberg.com
·
४३ मिनेट पहिले
Nasdaq 100 Advances 3% as Easing AI Anxiety Draws Dip Buyers In
Reuters
·
१० घण्टा पहिले
Mapping the Market: S&P 500 at risk of further losses
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd